SH2 Domain Containing Protein 3A (SH2D3A)

[Edit]

NSP1; Novel SH2-Containing Protein-1

SH2 Domain Containing Protein 3A (SH2D3A)
Adaptor proteins mediate interactions between membrane receptors and transcription factors through 1 or more domains in the adaptor protein. By searching an EST database for sequences with signal transduction motifs, Lu et al. (1999) identified a cDNA encoding a deduced 576-amino acid protein, which they named NSP1.
NSP1 also contains a potential SH3 interaction domain. Northern blot analysis detected significant levels of a 2.7-kb NSP1 transcript only in placenta, pancreas, kidney, lung, fetal kidney, and fetal lung.In contrast, contact with fibronectin resulted in little phosphorylation of NSP1 but increased phosphorylation of the p130-Cas associated with NSP1. Expression of NSP1 led to activation of the stress-activated protein kinase JNK1 (MAPK8), but not ERK2 (MAPK1).

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant SH2 Domain Containing Protein 3A (SH2D3A) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to SH2 Domain Containing Protein 3A (SH2D3A) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to SH2 Domain Containing Protein 3A (SH2D3A) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for SH2 Domain Containing Protein 3A (SH2D3A) CLIA Kit Customized Service Offer
n/a ELISA Kit for SH2 Domain Containing Protein 3A (SH2D3A) ELISA Kit Customized Service Offer
  1. "NSP1 defines a novel family of adaptor proteins linking integrin and tyrosine kinase receptors to the c-Jun N-terminal kinase/stress-activated protein kinase signaling pathway."J. Biol. Chem. 274:10047-10052(1999) [PubMed] [Europe PMC] [Abstract]
  2. "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment." Genome Res. 13:2265-2270(2003) [PubMed] [Europe PMC] [Abstract]
  3. "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
  4. "The DNA sequence and biology of human chromosome 19." Nature 428:529-535(2004) [PubMed] [Europe PMC] [Abstract]
  5. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  6. "A quantitative atlas of mitotic phosphorylation."Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract]
  7. "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
  8. "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation."Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract]
  9. "The consensus coding sequences of human breast and colorectal cancers." Science 314:268-274(2006) [PubMed] [Europe PMC] [Abstract]